# COVID-19

Analysing COVID19 (Novel Coronavirus) data

## Background

**Coronavirus disease 2019 (COVID-19)** is an infectious disease caused by **severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)**. 
The disease was first identified in 2019 in Wuhan, the capital of Hubei, China, and has since spread globally, resulting in the 2019â€“20 coronavirus pandemic.
The covid-19 has huge potential implications and this project is to dive into the available data and gain insights.

## Data

### Source

John Hopkins University CSSE [Novel Coronavirus (COVID-19) Cases data](https://systems.jhu.edu/research/public-health/ncov/): https://github.com/CSSEGISandData/COVID-19

*Bias*: Selection bias on confirmed to those tested there is discriminatory forces that determine who gets tested - age, availability, price/demographic, and on. 
These can change with time. Further, countries are investing to make the tests more available which affects the report.

### Tracking

Covid Tracking Projects: https://covidtracking.com

### Keywords

```
#COVID19
#covid19
#coronavirus
#CoronaVirus
#coronavirustexas
#Coronavirustexas
#coronavirusnewyork
#coronaviruscalifornia
```

---

## Report

### 03-25-2020

#### China: Cumulative cases by provinces over time, starting 10-Feb-2020

![](reports/03-25-2020/cn_cum.png)

The curve appears to be flattening, which is good.

#### China: New cases by provinces over time, starting 10-Feb-2020

![](reports/03-25-2020/cn_new.png)

Very few or no new cases, which is good.

#### Hubei, China: New cases over time, starting 10-Feb-2020

![](reports/03-25-2020/cn_new_hubei.png)

Three major spikes followed by a consistent drop, which is good.

#### USA: Cumulative cases over time, starting 10-Mar-2020

![](reports/03-25-2020/us_cum.png)

The curve exponentially increasing, which is concerning.

#### USA: New cases over time, starting 10-Mar-2020

![](reports/03-25-2020/us_new.png)

![](reports/03-25-2020/us_new2.png)

The curve increasing, but slower which is still concerning, with a glimmer of hope.